These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2700994)

  • 1. Molecular features of the H-2 class I and Qa antigens expressed on Gross virus induced AKR leukaemias.
    Festenstein H
    J Immunogenet; 1989; 16(4-5):329-33. PubMed ID: 2700994
    [No Abstract]   [Full Text] [Related]  

  • 2. The generation and specificity of cytotoxic T cells raised against syngeneic tumor cells bearing AKR/Gross murine leukemia virus antigens.
    Green WR; Nowinski RC; Henney CS
    J Exp Med; 1979 Jul; 150(1):51-66. PubMed ID: 109575
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells.
    Green WR
    J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of an "alloantigen"-like molecule is a general phenomenon in AKR leukaemias.
    Labeta M; Fernandez N; Festenstein H
    Transplant Proc; 1989 Feb; 21(1 Pt 1):578. PubMed ID: 2705236
    [No Abstract]   [Full Text] [Related]  

  • 5. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. II. Negative control by the Fv-1 locus in AKR mice of responder H-2b haplotype.
    Green WR
    J Immunol; 1984 May; 132(5):2665-71. PubMed ID: 6425410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. I. Isolation of a selectively resistant variant tumor subclone.
    Green WR
    Eur J Immunol; 1983 Nov; 13(11):863-70. PubMed ID: 6196206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of nonresponsiveness to AKR/Gross leukemia virus in AKR.H-2b:Fv-1b mice. An analysis of precursor cytotoxic T lymphocyte frequencies in young versus moderately aged mice.
    Wegmann KW; McMaster JS; Green WR
    J Immunol; 1991 Apr; 146(7):2469-77. PubMed ID: 2005406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resistance to cell-mediated cytotoxicity is correlated with reduction of H-2K gene products in AKR leukemia.
    Schmidt W; Festenstein H
    Immunogenetics; 1982; 16(3):257-64. PubMed ID: 6982849
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic control of the induction of cytolytic T lymphocyte responses to AKR/Gross viral leukemias. I. H-2-encoded dominant gene control.
    Green WR
    J Immunol; 1984 May; 132(5):2658-64. PubMed ID: 6425409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonal heterogeneity of anti-AKR/gross leukemia virus cytotoxic T lymphocytes. Evidence for two distinct antigen systems.
    Azuma H; Phillips JD; Green WR
    J Immunol; 1987 Oct; 139(7):2464-73. PubMed ID: 2821116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. II. Altered gp70 display and production of noninfectious virus particles by an insusceptible variant tumor.
    Green WR; Brown MA
    Eur J Immunol; 1983 Nov; 13(11):871-7. PubMed ID: 6196207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-dependent leukemia produced in thymectomized AKR mice by antiserum to leukemic cells.
    Kohn RR; Sciotto CG; Hensse S
    Exp Gerontol; 1978; 13(3-4):181-7. PubMed ID: 689114
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance to cellular immune response in AKR leukemias.
    Schäfer A; Schmidt W
    Eur J Immunol; 1986 Jul; 16(7):753-9. PubMed ID: 2424771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. H-2-restricted cytolytic T lymphocytes specific for a subclass of AKR endogenous leukemia virus-induced tumors: correlation of tumor cell susceptibility with expression of the gross cell surface antigen.
    Green WR
    J Immunol; 1980 Dec; 125(6):2584-90. PubMed ID: 6159413
    [No Abstract]   [Full Text] [Related]  

  • 15. H-2-specific antibodies induced by injection of syngeneic leukemia cells.
    Schmidt W
    Immunogenetics; 1987; 25(4):215-21. PubMed ID: 3570375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of antigens coded in murine leukemia viruses on thymocytes of allogeneic donor origin in AKR mice following syngeneic or allogeneic bone marrow transplantation.
    Wustrow TP; Good RA
    Cancer Res; 1985 Dec; 45(12 Pt 1):6428-35. PubMed ID: 2998600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COMPARISON OF TUMOUR ANTIGENS IN AKR AND GROSS VIRUS (PASSAGE A)-INDUCED LEUKAEMIAS.
    WAHREN B
    Nature; 1965 Jan; 205():409-10. PubMed ID: 14243441
    [No Abstract]   [Full Text] [Related]  

  • 18. Organization of the AKR Qa region: structure of a divergent class I sequence, Q5k.
    Weiss EH; Bevec D; Messer G; Schwemmle S; Grosshaus C; Steinmetz M; Schmidt W
    J Immunogenet; 1989; 16(4-5):283-90. PubMed ID: 2639903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The specificity of H-2-restricted cytotoxic T lymphocytes directed to AKR/Gross leukemia virus-induced tumors. III. Coordinate alterations in viral gp70 antigen expression and restoration of CTL-susceptibility to insusceptible variant tumors.
    Manjunath R; Graziano RF; Green WR
    J Immunol; 1986 Mar; 136(6):2271-9. PubMed ID: 3005407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variation in MHC antigenic profiles of tumor cells and its biological effects.
    Festenstein H; Schmidt W
    Immunol Rev; 1981; 60():85-127. PubMed ID: 6171505
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.